Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Avenge Bio
22 Strathmore Rd., STE. 241
Natick, MA 01760
Phone: 215-200-9192
https://avengebio.com/

Avenge Bio is an oncology-focused biotechnology company developing transformative cell-based immunotherapeutic products for the treatment of intractable solid tumors by incorporating its LOCOcyte platform. The LOCOcyte platform leverages proprietary engineered cells delivered to the local tumor environment that generate high concentrations of immune effector molecules in proximity to the tumor.

Key Contact
Name
Michael Heffernan
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
03/02/22 $45,000,000 Series A CAM Capital
Longitude Capital
Pappas Capital
Perceptive Advisors
Rock Springs Capital
undisclosed